major histocompatibility complex, class II, DR beta 4 ; Homo sapiens






230 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 17747 3,4-Methylenedioxyphenyl-, isopropylidenedioxyphenyl-, and benzyl-substituted chiral 2-aminosuccinimides and 3-aminopyrrolidines. Stereoselective investigations of potential anti-parkinsonian, antipsychotic, and anticonvulsant activities. J Med Chem 1977 Jun 1
2 1350267 A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis. Immunogenetics 1992 8
3 1354193 HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992 Sep 6
4 1412412 Population and family studies of HLA-DR4 by use of oligonucleotide typing. Tissue Antigens 1992 May 1
5 1553933 Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 1992 Apr 1
6 1590273 Radiation resistance in a doxorubicin-resistant human fibrosarcoma cell line. Am J Clin Oncol 1992 Jun 1
7 1639743 Clozapine-induced agranulocytosis in a Native American: HLA typing and further support for an immune-mediated mechanism. J Clin Psychiatry 1992 Jul 1
8 1701997 Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. Arthritis Rheum 1991 Jan 1
9 1710441 Is rheumatoid arthritis in Indians associated with HLA antigens sharing a DR beta 1 epitope? Ann Rheum Dis 1991 May 1
10 1714600 Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. Proc Natl Acad Sci U S A 1991 Aug 15 1
11 1716435 T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab 1991 Jun 1
12 1740588 HLA-DR4-associated nonresponsiveness to mountain-cedar allergen. J Allergy Clin Immunol 1992 Feb 2
13 1783573 Diversity in HLA-DR4-related DR,DQ haplotypes in Australia, Oceania, and China. Hum Immunol 1991 Dec 1
14 1869824 Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J Immunol 1991 Aug 15 4
15 1895259 Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility. J Rheumatol 1991 Jun 1
16 1910427 Immunogenetic heterogeneity in type I (insulin-dependent) diabetes among the Tunisian population. HLA-DR antigens and organ-specific autoantibodies (family study). J Autoimmun 1991 Jun 1
17 1937578 Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics 1991 1
18 1976136 HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II. J Natl Cancer Inst 1990 Oct 3 14
19 1993839 An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitized by Streptococcus mutans. J Immunol 1991 Mar 1 1
20 2210066 HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes 1990 Jan 6
21 2272662 HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes. Immunogenetics 1990 1
22 2369430 HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum 1990 Jul 1
23 2445717 Determination of DR beta 1 alleles of DR4/Dw subtypes by oligonucleotide probing. Hum Immunol 1987 Sep 1
24 2472003 Hypotheses on the molecular basis of susceptibility to rheumatoid arthritis. Scand J Rheumatol Suppl 1988 3
25 2489039 Reversal of HLA restriction by a point mutation in an antigenic peptide. Int Immunol 1989 2
26 2492197 HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 1989 Jan 2
27 2569325 Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein. Br J Cancer 1989 Jan 1
28 2583222 Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules. Eur J Immunol 1989 Oct 1
29 2617513 HLA-DQ antigens and DQ beta amino acid 57 of Japanese patients with insulin-dependent diabetes mellitus: detection of a DRw8DQw8 haplotype. Tissue Antigens 1989 Oct 4
30 2732676 Putative amino acid sequence of HLA-DRB chain contributing to rheumatoid arthritis susceptibility. J Exp Med 1989 Jun 1 1
31 2896069 Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res 1988 May 15 2
32 2904760 Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med 1988 Dec 23 1
33 2953314 HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Ann Rheum Dis 1987 Mar 1
34 3067866 Rheumatoid arthritis. Baillieres Clin Rheumatol 1988 Dec 2
35 3071483 Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study. Diabetologia 1988 Oct 1
36 3217930 Extended HLA haplotypes in families with insulin-dependent diabetes mellitus in northern Finland. Tissue Antigens 1988 Sep 2
37 3313816 Siblings with IgA nephropathy and diffuse proliferative glomerulonephritis (PGN) associated with identical HL-A antigens. Tokai J Exp Clin Med 1986 Nov 1
38 3459889 Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine. J Rheumatol 1986 Apr 1
39 3471665 HLA-DR effects in a large German IDDM dataset. Genet Epidemiol Suppl 1986 1
40 3486889 Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986 Jun 1
41 3490876 HLA antigens and Langerhans cell density in contact dermatitis. Br J Dermatol 1986 Oct 1
42 3493344 Increased frequency of Gm(1,2;21) phenotype in HLA-DR4 positive seropositive rheumatoid arthritis. J Rheumatol 1986 Oct 1
43 3501296 [Value of immunological studies in various forms of cardiomyopathy]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR 1987 1
44 3501473 Penicillamine induced polymyositis and dermatomyositis. J Rheumatol 1987 Oct 1
45 3556283 Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population. Diabetes 1987 Jul 2
46 3657791 Functional polymorphisms among HLA-DR4+ DR beta chains associated with limited peptide diversity. Mol Immunol 1987 May 1
47 3686517 HLA antigens in chronic pancreatitis. Tissue Antigens 1987 Oct 1
48 3726861 Interaction between HLA antigens and immunoglobulin (Gm) allotypes in susceptibility to type I diabetes. Tissue Antigens 1986 May 1
49 3871091 Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 1985 Jan 1
50 3875511 A particular subset of HLA-DR4 accounts for all or most of the DR4 association in type I diabetes. Diabetes 1985 Sep 1